Highlights and Quick Summary
Current Free Cash Flow Yield of Biofrontera AG Sponsored ADR is -45.04% (as of December 31, 2021)
- Free Cash Flow Yield for the quarter ending June 30, 2022 was -55.51% (a 1.56% increase compared to previous quarter)
- Year-over-year quarterly Free Cash Flow Yield increased by 121.42%
- Annual Free Cash Flow Yield for 2021 was -45.04% (a 150.08% increase from previous year)
- Annual Free Cash Flow Yield for 2021 was -18.01% (a -8.86% decrease from previous year)
- Annual Free Cash Flow Yield for 2020 was -19.76% (a -0.7% decrease from previous year)
Visit stockrow.com/BFAGY
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Free Cash Flow Yield of Biofrontera AG Sponsored ADR
Most recent Free Cash Flow Yieldof BFAGY including historical data for past 10 years.Interactive Chart of Free Cash Flow Yield of Biofrontera AG Sponsored ADR
Biofrontera AG Sponsored ADR Free Cash Flow Yield for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | – | -55.51% | -54.66% | – |
| 2021 | -45.04% | -25.07% | -20.84% | -24.37% | -45.04% |
| 2020 | -19.76% | -19.59% | -23.2% | -29.42% | -19.76% |
| 2019 | – | -19.9% | -16.19% | -15.88% | -19.9% |
| 2018 | – | – | – | -40.62% | -47.35% |
| 2017 | – | – | 0.0% | 0.0% | 0.0% |
| 2016 | 0.0% | – | – | – | 0.0% |
Business Profile of Biofrontera AG Sponsored ADR
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic